Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Harshal Abhyankar"'
Autor:
Qaiser Razi, Aryan Devrani, Harshal Abhyankar, G. S. S. Chalapathi, Vikas Hassija, Mohsen Guizani
Publikováno v:
IEEE Open Journal of the Communications Society, Vol 5, Pp 2765-2791 (2024)
Non-fungible tokens (NFTs) have become an exciting technology that provides a fresh perspective on asset ownership, provenance, and value exchange. NFTs, a blockchain-based technology, are distinct and indivisible cryptographic tokens used to confirm
Externí odkaz:
https://doaj.org/article/496eba9dd5ea428a838356714d58e024
Autor:
Karen Phaik Har Lim, Paul Milne, Michael Poidinger, Kaibo Duan, Howard Lin, Naomi McGovern, Harshal Abhyankar, Daniel Zinn, Thomas M. Burke, Olive S. Eckstein, Rikhia Chakraborty, Amel Sengal, Brooks Scull, Evan Newell, Miriam Merad, Kenneth L. McClain, Tsz-Kwong Man, Florent Ginhoux, Matthew Collin, Carl E. Allen
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 87-99 (2020)
Abstract: Langerhans cell histiocytosis (LCH) is a myeloproliferative disorder that is characterized by the inflammatory lesions with pathogenic CD1a+CD207+ dendritic cells (DCs). BRAFV600E and other somatic activating MAPK gene mutations have been i
Externí odkaz:
https://doaj.org/article/c86f478e226541b0bac33e2a435850d6
Autor:
Paul Milne, Harshal Abhyankar, Brooks Scull, Preeti Singh, Rikhia Chakraborty, Carl E. Allen, Matthew Collin
Publikováno v:
Blood Advances. 6:4901-4904
Autor:
Alexandra Tabachnikova, Ilaria Laface, Zoi Karoulia, Poulikos I. Poulikakos, Howard Lin, Alessia Baccarini, Amaia Lujambio, Jenielle Jobson, Markus G. Manz, Guray Akturk, Brian D. Brown, Sacha Gnjatic, Kenneth L. McClain, Anahita Rafiei, Jennifer Picarsic, Miriam Merad, Camille Bigenwald, Jessica Le Berichel, Steven T. Chen, Maria Casanova-Acebes, Carl E. Allen, Harshal Abhyankar, Rikhia Chakraborty, John A. Grout, Jerome Martin, C. Matthias Wilk, Rebecca Mancusi
Publikováno v:
Nature Medicine. 27:851-861
Langerhans cell histiocytosis (LCH) is a potentially fatal condition characterized by granulomatous lesions with characteristic clonal mononuclear phagocytes (MNPs) harboring activating somatic mutations in mitogen-activated protein kinase (MAPK) pat
Autor:
Dimitra, Stathi, Maria P, Yavropoulou, Carl E, Allen, Harshal, Abhyankar, Brooks, Scull, Marina, Tsoli, Evangelos, Andreakos, Gregory, Kaltsas, Polyzois, Makras
Publikováno v:
Pediatric hematology and oncology. 39(6)
Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplasia with a broad spectrum of clinical manifestations. The activation of the MAP kinase pathway plays an integral role in its pathogenesis with genetic alterations found in the m
Autor:
Michael Poidinger, Howard Lin, Kaibo Duan, Miriam Merad, Kenneth L. McClain, Naomi McGovern, Daniel J. Zinn, Evan W. Newell, Brooks Scull, Carl E. Allen, Rikhia Chakraborty, Florent Ginhoux, Karen Phaik Har Lim, Tsz-Kwong Man, Olive S. Eckstein, Thomas M. Burke, Matthew Collin, Harshal Abhyankar, Amel Sengal, Paul Milne
Publikováno v:
Blood Advances. 4:87-99
Langerhans cell histiocytosis (LCH) is a myeloproliferative disorder that is characterized by the inflammatory lesions with pathogenic CD1a(+)CD207(+) dendritic cells (DCs). BRAFV600E and other somatic activating MAPK gene mutations have been identif
Autor:
Dimitra Stathi, Maria P. Yavropoulou, Carl E. Allen, Harshal Abhyankar, Brooks Scull, Marina Tsoli, Evangelos Andreakos, Gregory Kaltsas, Polyzois Makras
Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplasia with a broad spectrum of clinical manifestations. The activation of the MAP kinase pathway plays an integral role in its pathogenesis with genetic alterations found in the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc546f80b0fde2c4e922e600c7afa2d4
Autor:
Fong Lam, Howard Lin, Carl E. Allen, Baruch Goldberg, Jay Greenberg, Michelle L. Hermiston, Hector R. Wong, Joseph Lubega, Lisa R. Forbes, Jordana Goldman, Tsz-Kwong Man, Trung C. Nguyen, Ivan K. Chinn, Jennifer E. Agrusa, Michael M. Henry, Daniel J. Zinn, Ahmed Naqvi, Michael Jeng, Nitya Gulati, Rikhia Chakraborty, Jessica Velasquez, Brooks Scull, Stephan Ladisch, Nader El Mallawaney, Kenneth L. McClain, Eyal Muscal, Dalia Bashir, Lauren K. Meyer, Michael B. Jordan, Harshal Abhyankar, Olive E. Eckstein
Publikováno v:
Blood advances, vol 5, iss 17
Blood Adv
Blood Adv
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by pathologic immune activation in which prompt recognition and initiation of immune suppression is essential for survival. Children with HLH have many overlapping clinical features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163be881531666aec57a30023c69125b
https://escholarship.org/uc/item/4617m929
https://escholarship.org/uc/item/4617m929
Autor:
Kala Y. Kamdar, Rikhia Chakraborty, M. Monica Gramatges, Tsz-Kwong Man, Olive S. Eckstein, Howard Lin, Harshal Abhyankar, Rayne H. Rouce, Jennifer E. Agrusa, Brooks Scull, Elmoataz Abdel Fattah, ZoAnn E. Dreyer, Joseph Lubega, Carl E. Allen, Nitya Gulati, Catherine M. Bollard, Judith F. Margolin, Terzah M. Horton, Julienne Brackett, Kenneth L. McClain, Nmazuo W. Ozuah, Nader Kim El-Mallawany
Publikováno v:
Cancers, Vol 12, Iss 3603, p 3603 (2020)
Cancers
Volume 12
Issue 12
Cancers
Volume 12
Issue 12
Hodgkin lymphoma (HL) histopathology is characterized by rare malignant Reed&ndash
Sternberg cells among an inflammatory infiltrate. We hypothesized that characteristics of inflammation in pediatric HL lesions would be reflected by the levels of
Sternberg cells among an inflammatory infiltrate. We hypothesized that characteristics of inflammation in pediatric HL lesions would be reflected by the levels of
Autor:
Harshal Abhyankar, Wendong Yu, Amel Sengal, Catherine M. Bollard, Meryl Hahne, Kenneth L. McClain, Robert William Ignacio Reyes, Camille Bigenwald, Olive S. Eckstein, Rikhia Chakraborty, Carl E. Allen, Brooks Scull, Walter Olea, Miriam Merad, Jessica Velazquez, Thomas M. Burke
Publikováno v:
Blood. 137(13)
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia characterized by granulomatous lesions containing pathological CD207+ dendritic cells (DCs) with persistent MAPK pathway activation. Standard-of-care chemotherapies are inadequa